J. Baselga

European Code Against Cancer and scientific justification: third version (2003)

Peter Boyle, Philippe Autier, Harry Bartelink et al. · Annals of Oncology · 2003 · 307 citations · Full text

Public Health, Oncology, Cancer Control +4

TACE is required for the activation of the EGFR by TGF‐α in tumors

María Borrell-Pagés, Federico Rojo, Joan Albanell et al. · The EMBO Journal · 2003 · 274 citations · Full text

Life Sciences, Molecular Biology, Oncology +10

Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells

Deepak Raina, Yoshiaki Uchida, Akriti Kharbanda et al. · Oncogene · 2013 · 107 citations · Full text

Medicine, Cancer Biology, Oncology +17

Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer

J. Carpenter, H. Roché, Mario Campone et al. · Journal of Clinical Oncology · 2005 · 98 citations

Medicine, Oncology, Pharmacology +14

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Wenhao Shi, Tingting Jiang, Paolo Nucíforo et al. · Annals of Oncology · 2016 · 74 citations · Full text

Medicine, Genetics, Oncology +17